Riskpilot← Back to searchSign inGet full accessCOLOALERT AS
ASActiveOrg 913028570Bolignummer H0504 Storgata 61, 4307 SandnesResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20140 employees
Revenue 2024
NOK 0
EBITDA margin
—
+54% vs 2023
Equity ratio
99.9%
Financial strength
Net profit 2024
NOK -62K
-100% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -52K | +54% |
| Net profit | NOK -62K | -100% |
| Total assets | NOK 5,7M | -21% |
| Equity | NOK 5,7M | -1% |
| Employees | 0 | — |
Legal name
COLOALERT AS
Org number
913028570
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
4. februar 2014
Share capital
NOK 832 355
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Drive med utvikling, lisensiering og salg av medisinsk diagnostiske tester.
Address
Bolignummer H0504 Storgata 61, 4307 Sandnes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 492 | 184 | 1 949 | 430 | 2 198 | 785 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −23 | −14 |
| EBITDA | −15 | −12 | −187 | 432 | −563 | 1 536 | 380 | 1 966 | −2 062 | −114 | −52 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −15 | −12 | −187 | 432 | −563 | 1 536 | 380 | 1 966 | −2 062 | −114 | −52 |
| Net financials | 0 | 0 | 0 | 875 | −15 | −7 | −146 | −247 | 4 998 | 12 603 | −9 |
| Profit before tax | −15 | −12 | −187 | 1 307 | −579 | 1 529 | 234 | 1 719 | 2 936 | 12 489 | −62 |
| Tax | −0 | −0 | −0 | −0 | −0 | 209 | 52 | 380 | 646 | −0 | −0 |
| Net profit | −15 | −12 | −187 | 1 248 | −579 | 1 320 | 182 | 1 339 | 2 290 | 12 489 | −62 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 9 | 0 | −190 | 1 924 | 1 269 | 4 176 | 2 083 | 5 065 | 6 661 | 7 265 | 5 703 |
| Equity | 9 | −3 | −190 | 1 444 | 866 | 2 186 | 2 367 | 856 | 896 | 5 762 | 5 700 |
| Long-term debt | 0 | 0 | 0 | 0 | 1 | 0 | −2 117 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 3 | 0 | 480 | 403 | 1 991 | 1 832 | 4 209 | 5 765 | 1 503 | 3 |
| Total debt | 0 | 3 | 0 | 480 | 404 | 1 991 | −285 | 4 209 | 5 765 | 1 503 | 3 |
EBITDA margin
-5246300.0%
This company
15.8%
Market median
-33204530% vs market
20142024
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20142024
Return on equity
-1.1%
This company
18.4%
Market median
-106% vs market
20142024
Net profit margin
-6178600.0%
This company
8.1%
Market median
-76279112% vs market
20142024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20142024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DS Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Citron As | Company | 33.3% | 33.3% | 2022 |
Rologen As | Company | 33.3% | 33.3% | 2022 |
Hannibal Invest As | Company | 33.3% | 33.3% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rologen As
COLOALERT AS Board members of COLOALERT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dagfinn Steinar Øgreid | Chief Executive Officer | 0 companies |
| Hans Johan Hekland | Chairman | 0 companies |
| Roger Løvlie | Board of Directors | 0 companies |